Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

Lilly has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for ...

Eli Lilly and Company (NYSE:LLY) on Thursday announced a $1.8 billion investment to expand its manufacturing operations in ...

AMERICAN pharmaceutical company Eli Lilly has invested US$1bn into the expansion of its manufacturing site in Limerick, ...

Eli Lilly and Company is expanding its manufacturing footprint in Ireland with a $1.8B investment to boost production of ...

Eli Lilly has again upped the ante in scaling up its manufacturing footprint, this time revealing an investment totaling $1.8 billion to expand production capacity at two plants in Ireland. | Eli ...

Nearly $1 billion will go toward expanding a facility that last year began making medicines for the company's new diabetes and obesity treatments.

This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 2020, ...

Indianapolis-based Eli Lilly and Co. on Thursday announced plans to spend $1.8 billion on two of its manufacturing sites in Ireland to boost production of medicines for Alzheimers ...

Company ups manufacturing investment in Limerick by $1 billion; unveils new $800 million Kinsale facility New investment will enhance global medicine production, benefiting millions of patients ...